INTRODUCTION
Agonist occupation of a wide variety of cell-surface receptors increases the activity of at least one isoform of phosphoinositidase C (PIC) to enhance the hydrolysis of the minor membrane phospholipid, PtdIns(4,5)P # . This hydrolysis generates both Ins(1,4,5)P $ and 1,2-diacylglycerol which are able to mobilize Ca# + from intracellular stores and activate protein kinase C (PKC) respectively [1] . The sensitivity and responsiveness of cells to activation of cell-surface receptors may be influenced by the internalization and degradation of such receptors. Other components of this pathway may be similarly regulated, such that down-regulation of both G-proteins [2] and the Ins(1,4,5)P $ receptor [3] may occur following exposure to agonists for many hours. These processes may mediate cellular desensitization to relatively long periods of agonist exposure.
The phosphoinositide pathway is also subject to acute regulation, a striking example of which is the rapid but often partial desensitization of PIC activity that occurs within seconds of agonist occupation of muscarinic [4] [5] [6] , and other receptor types [7, 8] . Additionally, features may exist which have the potential to influence the magnitude of cellular responses and their sensitivity to agonist. One such feature may result from the activation of PKC(s) and indeed this has been implicated in the limitation of muscarinic receptor-mediated activation of PIC [9] [10] [11] [12] [13] [14] H]scopolamine methyl chloride ; PDBu, phorbol 12,13-dibutyrate ; PIC, phosphoinositidase C ; PKC, protein kinase C ; TCA, trichloroacetic acid.
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elements were downstream of the receptor. The PKC inhibitor, Ro-318220, protected against PDBu but did not enhance responses to maximal concentrations of carbachol, indicating no feedback inhibition by agonist-activated PKC. Muscarinic antagonist activity of Ro-318220 complicated such assessment at low agonist concentrations. Carbachol or PDBu induced cytosol to membrane translocation of PKCα. This was faster and possibly greater with PDBu, which may explain the lack of feedback by agonist-activated PKC. These results indicate that, in SH-SY5Y cells, PDBu activation of PKC preferentially inhibits rapid muscarinic receptor-mediated phosphoinositide and Ca# + responses via suppression of PtdIns(4,5)P # hydrolysis. This is at least partially through inhibition of G q -protein\ phosphoinositidase C coupling. However, at least at high agonist concentrations, a major agonist-mediated PKC feedback is not present in these cells. studies demonstrate the potential for PKC-mediated inhibition of phosphoinositide responses by the use of phorbol esters, few have explored the role of muscarinic receptor-mediated PKC feedback regulation and the site(s) of PKC action. Furthermore, PIC activity has generally been assessed by measurement of the accumulation of total [$H]inositol phosphates ([$H]InsP x ) in Li + -blocked cells over periods of many minutes. While this technique provides an index of total PIC activity, the rapid desensitization of muscarinic receptor-mediated activation of PIC means that PIC activity is not constant over such time periods. Thus, accumulation of [$H]InsP x over many minutes will provide information about a partially desensitized receptor. Regulatory features under such circumstances may differ from those of a fully sensitized receptor [16] .
In this study we have examined the potential regulatory influence of PKC, activated by either phorbol ester or agonist occupation of muscarinic receptors (predominantly M $ [17] ), on phosphoinositide and [Ca# + ] i signalling in the human neuroblastoma cell line, SH-SY5Y.
MATERIALS AND METHODS

Cell culture
Experiments were performed on SH-SY5Y cells of passages 70-90. Cell culture was carried out as previously described [16] and cells harvested with 10 mM Hepes containing 154 mM NaCl and 0.54 mM EDTA (pH 7.4). (1, 4, 5) In these experiments and those described below, the [Ca# + ], determined with fura-2 [18] , was either 2-10 µM in nominally Ca# + -free conditions or buffered to 50-100 nM with EGTA. Where required the PKC inhibitor, Ro-318220, was added 10 min before and phorbol 12,13-dibutyrate (PDBu) 5 min before carbachol. Cells (90 µl, 100-300 µg of protein) were added to 10 µl of agonist at 37 mC and reactions terminated with an equal volume of ice-cold 1 M trichloroacetic acid (TCA). Ins(1,4,5)P $ was extracted and measured by specific radioreceptor assay as described elsewhere [16] and referenced to total cellular protein determined [19] in 0.1 M NaOH digests using bovine albumin fraction V as standard.
Generation of Ins
Cells were treated for 24 h with phorbol ester to down-regulate PKC by addition of 1 µM PDBu to confluent cell monolayers in 24-well plates (approx. 200 µg of protein\well). Vehicle (DMSO 0.1 %, v\v) was added to control cultures. After 24 h, cells were washed and equilibrated in Krebs\Hepes buffer (1 ml) for 30 min at 37 mC. Buffer was replaced with 100 µl of agonist. Where required, PDBu or vehicle were added 5 min prior to agonist. Reactions were terminated with an equal volume of ice-cold 1 M TCA and processed as above.
Generation of Ins(1,4,5)P 3 in permeabilized cells
Cells were harvested and resuspended in 1.6 ml of an intracellularlike buffer (ICB) [pH 6.9, composition (mM) : Hepes 20, KCl 10, [21] . Cells in 24-well multiwells (20-30 % confluent, 30 µg of protein\well) were washed and incubated for 1 h at 37 mC (in the light) in 1 ml of Krebs\Hepes with [$H]NMS and the test agent. Non-specific binding was determined with 10 µM atropine. Cells were washed rapidly with two 1 ml volumes of ice-cold buffer and digested with 0.5 ml of 0.1 M NaOH. This was neutralized with 0.5 ml of 1 M TCA and $H determined by liquid scintillation spectrometry in 5 ml of Floscint IV.
Preparation of cell extracts and immunoblot analysis of PKC isoenzymes
Western blots indicate that PKCα and PKCβ1 are the predominant PKC isoforms in SH-SY5Y cells [22] . As an index of PKC activation, the translocation of PKCα from the cytosolic to membrane fraction was therefore determined following carbachol or PDBu treatment.
Harvested cells were washed twice and suspended in Krebs\ Hepes buffer. Cells (300 µl, approx. 1.5 mg of protein) were incubated with 1 mM carbachol or 1 µM PDBu at 37 mC for the indicated times. Cells were pelleted (10 000 g, 3 min) and lysed in ice-cold homogenization buffer (20 mM Tris\HCl, 1 mM dithiothreitol, 5 mM EGTA, 2 mM EDTA, 0.5 mM PMSF, 1 µg\ml aprotinin, 10 µM benzamidine hydrochloride, 5 µM iodo-acetamide, pH 7.4) using 10 passes of a motor-driven glassTeflon homogenizer. Homogenates were centrifuged (33 000 g, 1 h, 4 mC) to yield supernatants (cytosolic extracts) and pellets (membrane fractions). Samples were denatured by boiling in an equal volume of sample buffer [50 mM Tris, 2 % SDS, 0.1 % Bromophenol Blue, 10 % (v\v) glycerol, 5 % (v\v) mercaptoethanol] and subjected to SDS\PAGE using a 10 % running gel. Proteins were transferred to nitrocellulose which was blocked (20 mC, 1 h) with 5 % (w\v) dry milk in TTBS (20 mM Tris\HCl, 0.15 M NaCl, 0.05 % Tween-20, pH 7.5). Mouse anti-PKCα antibodies (1 : 3000 in TTBS, 1 % dry milk) were then added for 2 h followed by horseradish peroxidase-labelled anti-(mouse IgG) antibody for 1 h. Nitrocellulose was washed following both incubations with TTBS (2i1 min, 1i15 min, 2i5 min). Immunoreactive bands were detected with enhanced chemiluminescence (ECL) reagents and exposure to Hyperfilm-ECL.
Statistics and data presentation
Inhibition curves and IC
&! values were determined with Graph-PAD (Academic Press Inc. 1986) using a standard four-parameter logistic equation. Where full time courses of carbachol-mediated responses were compared with and without treatment with PDBu, analysis was by two-way analysis of variance (ANOVA). Comparisons between individual group means was by two-tailed, unpaired, Student's t-test. Multiple comparisons between group means were by Duncan's multiple-range test at P 0.05 and P 0.01 following one-way ANOVA with P 0.05. For clarity all data are presented as meanspS.E.M.
Materials
Reagents of analytical grade were obtained from the suppliers listed previously [16, 20, 23] or from Sigma (Poole, U.K.). In addition, PDBu, calphostin-C and chelerythrine chloride were from Calbiochem (Nottingham, U.K.). Ro-318220 was a gift from Dr. 
RESULTS AND DISCUSSION
This study examined the effects of phorbol ester activation of PKC on the accumulation of Ins(1,4,5)P $ and the elevation of [Ca# + ] i in SH-SY5Y cells. The potential effects of altered metabolism of Ins(1,4,5)P $ on signalling patterns were assessed by measurement of agonist-mediated accumulation of total [$H]InsP x and changes in (poly)phosphoinositides. To investigate the site of PKC action, the effects of phorbol ester on Ins(1,4,5)P $ accumulation mediated by direct G-protein activation with GTP[S] in permeabilized cells were determined. The PKC inhibitor, Ro-318220, and down-regulation of PKC by long-term phorbol ester treatment were used to characterize the effects on phosphoinositide signalling of agonist-mediated, as opposed to phorbol ester-mediated, PKC activation.
PDBu attenuates carbachol-mediated Ins(1,4,5)P 3 and [Ca 2 + ] i signalling
Maximal concentrations of carbachol (1 mM) produced rapid but transient peaks of Ins(1,4,5)P $ accumulation which subsided over the following minute to lower but sustained levels ( Figure   Figure 1 PDBu attenuated carbachol-mediated elevations of Ins (1, 4, 5) 1A) confirming the biphasic nature of this response [5, 16, 24] . Pretreatment of cells for 5 min with 1 µM PDBu and its presence throughout the carbachol challenge significantly (P 0.05) reduced both peak and sustained accumulations ( Figure 1A ). The greatest effect was on the transient peak, which was reduced by 53 % compared with a reduction of 20 % during the sustained phase (5 min after carbachol addition). This emphasizes that regulatory influences may differ during different phases of receptor activation [16] and, although the basis of this is unclear, differences would be missed by measuring [$H]InsP x accumulation over many minutes.
The Ins(1,4,5)P $ response to carbachol was paralleled by changes in [Ca# + ] i . Thus, there was a rapid peak elevation of [Ca# + ] i which subsided to a lower but sustained level within 1 min ( Figure 1B) . PDBu attenuated the peak [Ca# + ] i response (change of 424p33 nM versus 590p31 nM, n l 3, P 0.005) but had no effect on the sustained component (change of 109p3 nM versus 103p7 nM, n l 3) confirming a preferential effect on peak responses (see Figure 1B for example).
Translocation of PKCα immunoreactivity
Western blot analysis demonstrated that either carbachol (1 mM) or PDBu (1 µM) provoked translocation of PKCα from the cytosolic to particulate fraction ( Figure 2 ). Translocation mediated by PDBu occurred within 1 min whereas there was a 1-2 min lag before detectable carbachol-mediated translocation. Immunoreactivity associated with the particulate fraction also suggested that PDBu may produce a greater translocation of PKCα than carbachol. 
Extracellular
PDBu attenuated carbachol-mediated Ins(1,4,5)P 3 accumulation by inhibiting hydrolysis of PtdIns(4,5)P 2
The accumulation of either Ins Figure 4A ). There was an initial rapid accumulation over the first 1 min followed by a slower but sustained accumulation. This biphasic accumulation suggests that the biphasic Ins(1,4,5)P $ response may reflect the rapid partial desensitization of PIC as discussed elsewhere [4] . PDBu caused a significant (P l 0.0009) inhibition of [$H]InsP x accumulation over the course of the experiment ( Figure 4A [26] and inositol phospholipid movements between different cellular compartments [27] , no effects of PDBu were observed in the absence of muscarinic receptor activation.
Under these conditions, carbachol produced a rapid accumulation of [$H]InsP x over the first 60 s followed by a sustained elevation ( Figure 4B 
PDBu inhibition of phosphoinositide signalling occurs, at least in part, at the post-receptor level
Over a period of 60 min, PDBu had no effect upon the binding of accumulation of Ins(1,4,5)P $ in permeabilized cells ( Figure 5A ). In contrast to the response in intact cells, carbachol mediated a slower increase in Ins(1,4,5)P $ which peaked at 120 s and then declined to a sustained component. The increase in Ins(1,4,5)P $ following addition of GTP[S] displayed different kinetics such that there was a lag following addition of GTP[S] and a peak at 180 s. (This level was then sustained for a further 120 s.) The slower rate of Ins(1,4,5)P $ accumulation in response to GTP[S] may be due to the dependence on basal GTP\GDP exchange [28] , whereas this will be facilitated by muscarinic receptor activation leading to a more rapid activation of PIC.
Treatment of permeabilized cells with PDBu had no effect on basal Ins(1,4,5)P $ (24.5p5.0 control, 30.1p3.9 PDBu-treated, pmol\mg of protein, n l 7). However, PDBu significantly (P 0.001) reduced the maximal Ins(1,4,5)P $ response to carbachol (93.3p10.2 versus 146.5p11.3, n l 7) demonstrating that, after permeabilization, PDBu-sensitive elements of Ins(1,4,5)P $ accumulation were retained. This further supports a primary effect of PDBu on Ins(1,4,5)P $ generation rather than the [Ca# + ] i response as the [Ca# + ] is effectively clamped to that of the buffer (300 nM). The maximal Ins(1,4,5)P $ response to GTP[S] was also significantly attenuated by PDBu ( Figure 5B ). Thus at least a component of PDBu sensitivity is at the post-receptor level in these cells. This is in contrast to previous studies indicating a direct effect of phorbol esters on muscarinic M $ receptors in HT-29 cells [14] and PIC-linked muscarinic receptors of astrocytes [13] . However, data from the current study agree with previous reports of the inhibition of phosphoinositide responses by phorbol esters at the post-receptor level [8, 11] . As Gα q/"" is not phosphorylated in response to either PDBu or agonist [8] , inhibition is unlikely to be at this level. However, PIC-β, which probably mediates muscarinic receptor-mediated hydrolysis of PtdIns(4,5)P # , is a substrate for PKC [29] . Although this phosphorylation does not affect catalytic activity, it may alter interaction with Gα q/"" , thereby limiting activation [29] .
As the kinetics of Ins(1,4,5)P $ accumulation in permeabilized cells differed between carbachol and GTP[S], the proportion of PDBu sensitivity attributable to events at the post-receptor level could not be estimated. Phosphorylation of the receptor itself may be associated with desensitization [4] and it is possible that PDBu sensitivity could also occur at the receptor following phosphorylation by PKC. Indeed human muscarinic M $ receptors expressed in CHO cells are a substrate for PKC [30] although in those cells PKC may not mediate the major part of agonist-sensitive phosphorylation [31] . Treatment with the PKC inhibitor, Ro-318220 (10 µM), for 10 min had no effect on carbachol-induced peak or sustained Ins(1,4,5)P $ elevations ( Figure 5B ) these results indicate a lack of PKC feedback regulation of phosphoinositide signalling unless PKC is activated by PDBu.
Ins(1,4,5)P $ accumulation remained biphasic in cells treated with Ro-318220 (results not shown). This observation and the lack of effect of PDBu on the shape of the biphasic profile of Ins(1,4,5)P $ accumulation and [$H]InsP x accumulation (in Li + -blocked cells), indicates that PKC activation does not underlie the rapid desensitization of PIC activity that occurs within seconds of agonist exposure. This desensitization may, therefore, be related to phosphorylation of the muscarinic receptor by a receptor-specific kinase or other mechanisms such as the rapid, sustained and marked depletion of PtdIns(4,5)P # ( Figure 4C ) [4] .
Inhibition by PKC inhibitors of [ 3 H]NMS binding to human muscarinic M 3 receptors
Although the above data indicate a lack of agonist-mediated PKC feedback at maximal concentrations of carbachol, at submaximal agonist concentrations, when PIC is not maximally activated, such feedback may be relevant. Protocols designed to examine this would require the use of Ro-318220 at submaximal agonist concentrations. However, studies within our laboratory had indicated that Ro-318220 may be a muscarinic antagonist. Thus, the inhibition of [$H]NMS binding by Ro-318220 and a number of other PKC inhibitors having differing modes of action [32] was assessed.
All of the PKC inhibitors reduced [$H]NMS binding ( Figure  6 ). Assuming competitive interaction and using the ChengPrusoff factor [33] 
Effects of long-term PDBu treatment on phosphoinositide signalling
To overcome the antagonistic activity of Ro-318220 at the muscarinic receptor at submaximal agonist concentrations we sought to down-regulate PKC by long-term PDBu treatment. This has been reported to down-regulate at least some isoforms of PKC [12, 14, 34, 35] . Thus, if agonist activation of PKC mediates negative feedback, then down-regulation may enhance PIC activity.
Exposure to PDBu for either 24 h or 5 min prior to carbachol did not affect basal levels of Ins(1,4,5)P $ (12.8p4.1, n l 9) but significantly reduced peak responses. This occurred at maximal (1 mM) concentrations of carbachol (24 h, 139.2p7.9 ; 5 min, 125.8p17.7 ; untreated, 235.0p17.7, P 0.05) and at the EC &! (25 µM) (24 h, 54.2p8.0 ; 5 min, 69.5p14.6 ; untreated, 107.8p14.3, n l 3, P 0.01, all data expressed as pmol\mg of protein, n l 3).
The current study was in marked contrast to those reporting potentiation of agonist-mediated phosphoinositide responses following long-term phorbol ester treatment [34, 35] . Such an effect is not unprecedented [36] and may well be receptor-and\or cell-dependent [37] . This may result from the differential downregulation of PKC isoforms by phorbol esters and it is possible that in the current study the isoform responsible for inhibition was not sufficiently down-regulated. However, loss of PKC is unlikely to be the only consequence of long-term phorbol ester treatment. Indeed in SH-SY5Y cells, such a protocol resulted in a loss of [$H]NMS binding [38] . Whether other components of signalling pathways are affected is unclear but interpretation of altered phosphoinositide responses following this protocol is very difficult.
Conclusions
The current study indicates that the activation of PKC by PDBu inhibits muscarinic receptor-mediated Ins(1,4,5)P $ accumulation and [Ca# + ] i elevation by reducing the hydrolysis of PtdIns(4,5)P # at least partially at the post-receptor level. The rapid, transient phases of the biphasic responses are preferentially affected. Although we cannot eliminate an effect at sub-maximal agonist concentrations, the data provide no evidence of an effect of agonist-mediated PKC activation on phosphoinositide and [Ca# + ] i signalling. This is in contrast to findings with a number of other receptor types [8, [39] [40] [41] [42] and also an indication that in some instances PKC, following direct activation of G-proteins, can inhibit phosphoinositide responses [8] .
Divergence between phorbol ester-mediated and agonistmediated PKC activation may, however, be a common phenomenon. Thus, while phorbol esters desensitized PIC-linked responses to bombesin in Swiss 3T3 fibroblasts [43] and histamine in immortalized hypothalamic GT1-7 neuronal cells [44] , PKC was not involved in agonist-mediated desensitization. The ability of PKC, activated by means other than phorbol ester treatment, to influence PIC may therefore be dependent upon both cell and receptor type through, for example, differences in the level or isoforms of PKC and PIC expressed and\or the susceptibility of receptors to agonist-and PKC-dependent phosphorylation.
Although the association between translocation and activation should be made with caution, the current study suggested that PDBu provoked a greater activation of PKC than carbachol. Whether this difference is sufficient to account for the ability of PDBu, but not carbachol, to activate a PKC feedback loop is unclear. Aside from a more selective activation of isoenzymes other than PKCα by PDBu compared with carbachol, differences in the time course of PKC activation may also be important. Thus, when PDBu was used, PKC was maximally activated (assessed by translocation of PKCα) at the point of agonist addition. However, maximal activation of PKC by carbachol may be delayed and peak of Ins(1,4,5)P $ accumulation, which shows greatest sensitivity to PDBu, occurs prior to maximal activation of PKC. An existing agonist-mediated PKC activation may, however, limit activation of PIC by other receptor types. The combination of a lower sensitivity to PKC and a lower level of PKC activation by carbachol compared with PDBu could account for the lack of agonist-mediated PKC feedback during sustained responses. In the context of apparent Ca# + and PKCsensitive components of agonist-mediated Ins(1,4,5)P $ accumulation (see above) it is also interesting to speculate that agonistmediated PKC feedback could be of more importance when Ca# + facilitation of PIC is reduced or absent, for example during an
